Today's biggest pre-market stock movers: ALNA, NRBO, OGEN and more
Today's biggest pre-market stock movers: ALNA, NRBO, OGEN and more
Gainers
赢家
$Allena Pharmaceuticals(ALNA.US)$ rose 40.13% to $0.906 in pre-market trading as the company issued a clinical and corporate update.
$NeuroBo Pharmaceuticals(NRBO.US)$ rose 28.55% to $1.72 in pre-market trading after gaining around 10% on Monday.
$Oragenics(OGEN.US)$ rose 25.85% to $0.595 in pre-market trading. The company reported in Form 4 filing that Director Robert Koski bought 1 million shares at an average price of $0.47 per share.
$Immix Biopharma(IMMX.US)$ rose 23.53% to $7.14 in pre-market trading. Immix Biopharma shares jumped 62% on Monday after the company announced the FDA granted Rare Pediatric Disease designation for IMX-110 for the treatment of a life-threatening form of pediatric cancer in children, rhabdomyosarcoma.
$TherapeuticsMD(TXMD.US)$ rose 12.3% to $0.442 in pre-market trading. TherapeuticsMD, last month, said that the FDA could not approve revisions to certain manufacturing testing limits for Annovera through the supplemental marketing application previously submitted by the Company.
$Liquidia(LQDA.US)$ rose 9.90% to $5.649 in pre-market trading. Liquidia named Dr. Roger Jeffs as Chief Executive Officer (CEO) effective January 3, 2022.
$Borr Drilling(BORR.US)$ rose 9.3% to $2.36 in pre-market trading. Borr Drilling recently reported an agreement to defer $1.4 billion of debt maturities and yard instalments to 2025.
$AEterna Zentaris(AEZS.US)$ rose 9.2% to $0.43 in pre-market trading. Aeterna Zentaris recently named Giuliano La Fratta as Chief Financial Officer.
$TPI Composites(TPIC.US)$ rose 6.6% to $16.05 in pre-market trading.
$Allena PharmPharmticals(ALNA.US)$在盘前交易中，该公司发布了最新的临床和企业报告，股价上涨40.13%，至0.906美元。
$NeuroBo制药公司(NRBO.US)$在周一上涨约10%后，该股在盘前交易中上涨28.55%，至1.72美元。
$Oragenics(OGEN.US)$在盘前交易中，该公司股价上涨25.85%，至0.595美元。该公司在Form 4备案文件中报告称，董事罗伯特·科斯基以每股0.47美元的平均价格购买了100万股票。
$ImMix Biophma(IMMX.US)$在盘前交易中，该股上涨23.53%，至7.14美元。ImMix Biophma股价周一上涨62%，此前该公司宣布，FDA批准IMX-110治疗罕见的儿科疾病，用于治疗一种危及生命的儿童癌症-横纹肌肉瘤。
$TreateuticsMD(TXMD.US)$在盘前交易中，该公司股价上涨12.3%，至0.442美元。TreateuticsMD上个月表示，FDA不能通过该公司之前提交的补充营销申请批准对Annovera的某些制造测试限制的修订。
$Liqudia(LQDA.US)$在盘前交易中，该公司股价上涨9.90%，至5.649美元。Liqudia任命Roger Jeffs博士为首席执行官(CEO)，自2022年1月3日起生效。
$Borr钻探(BORR.US)$在盘前交易中，该股上涨9.3%，至2.36美元。Borr Drilling最近报告了一项协议，将14亿美元的债务到期日和院子分期付款推迟到2025年。
$Eeterna Zentaris(AEZS.US)$在盘前交易中，该股上涨9.2%，至0.43美元。Aeterna Zentaris最近任命Giuliano La Fratta为首席财务官。
$TPI复合材料(TPIC.US)$在盘前交易中，该股上涨6.6%，至16.05美元。
Losers
失败者
$Valneva(VALN.US)$ fell 14.24% to $43.73 in pre-market trading. Valneva, last month, said its COVID-19 vaccine candidate was efficient as a booster for people who had received the same shot as an initial vaccination.
$Eco Wave Power(WAVE.US)$ fell 11.33% to $5.32 in pre-market trading after jumping 40% on Monday.
$Creative Medical Technology(CELZ.US)$ shares fell 10.59% to $2.861 in pre-market trading after jumping around 45% on Monday.
$Intra-Cellular Therapies(ITCI.US)$ shares fell 8.69% to $47.50 in pre-market trading after the company reported a $400 million common stock offering.
$Blue Hat Interactive Entertainment Technology(BHAT.US)$ fell 8.1% to $0.4088 in pre-market trading.
$Armstrong Flooring(AFI.US)$ fell 7.2% to $2.57 in pre-market trading. Armstrong Flooring shares climbed around 40% on Monday after the company said it is exploring a sale of the business.
$Abcam(ABCM.US)$ shares fell 6.2% to $22.41 in pre-market trading. Alamar Biosciences and Abcam reported a strategic partnership to further understanding of the human proteome.
$Tiziana Life Sciences(TLSA.US)$ shares fell 3.67% to $1.05 in pre-market trading after climbing around 14% on Monday.
$Valneva(VALN.US)$在盘前交易中，该股下跌14.24%，至43.73美元。上个月，Valneva表示，其新冠肺炎候选疫苗对于那些接种了与初始疫苗相同的疫苗的人来说是有效的加强剂。
$Eco Wave Power(WAVE.US)$在盘前交易中下跌11.33%，至5.32美元，周一跃升40%。
$创新医疗技术(CELZ.US)$在周一的盘前交易中，该公司股价下跌10.59%，至2.861美元，此前该公司股价曾跃升约45%。
$细胞内治疗(ITCI.US)$在盘前交易中，该公司股价下跌8.69%，至47.50美元，此前该公司公布了4亿美元的普通股发行。
$蓝帽子(美国)$在盘前交易中，该公司股价下跌8.1%，至0.4088美元。
$阿姆斯特朗地板(AFI.US)$在盘前交易中下跌7.2%，至2.57美元。阿姆斯特朗地板公司股价周一上涨约40%，此前该公司表示正在研究出售该业务。
$Abcam(ABCM.US)$在盘前交易中，该公司股价下跌6.2%，至22.41美元。Alamar Biosciences和Abcam报告了进一步了解人类蛋白质组的战略伙伴关系。
$Tiziana Life Science(TLSA.US)$股价在周一攀升约14%后，在盘前交易中下跌3.67%，至1.05美元。